[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8663 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 8663
To require the Science and Technology Directorate in the Department of
Homeland Security to develop greater capacity to detect, identify, and
disrupt illicit substances in very low concentrations.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 7, 2024
Mr. LaLota (for himself and Mr. Correa) introduced the following bill;
which was referred to the Committee on Homeland Security
_______________________________________________________________________
A BILL
To require the Science and Technology Directorate in the Department of
Homeland Security to develop greater capacity to detect, identify, and
disrupt illicit substances in very low concentrations.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLES.
This Act may be cited as the ``Detection Equipment and Technology
Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024''
or the ``DETECT Fentanyl and Xylazine Act of 2024''.
SEC. 2. ENHANCING THE CAPACITY TO DETECT, IDENTIFY, AND DISRUPT DRUGS
SUCH AS FENTANYL AND XYLAZINE.
Section 302 of the Homeland Security Act of 2002 (6 U.S.C. 182) is
amended--
(1) in paragraph (13), by striking ``and'' at the end;
(2) in paragraph (14), by striking the period at the end
and inserting ``; and''; and
(3) by adding at the end the following:
``(15) carrying out research, development, testing,
evaluation, and cost-benefit analyses to improve the safety,
effectiveness, and efficiency of equipment and reference
libraries for use by Federal, State, local, Tribal, and
territorial law enforcement agencies for the accurate detection
of drugs or the disruption of drug trafficking for drugs such
as fentanyl and xylazine, including, but not limited to--
``(A) portable equipment that can detect and
identify drugs with minimal or no handling of the
sample;
``(B) equipment that can separate complex mixtures
containing low concentrations of drugs and high
concentrations of cutting agents into their component
parts to enable signature extraction for field
identification and detection; and
``(C) technologies that use machine learning or
artificial intelligence (as defined in section 5002 of
the National Artificial Intelligence Initiative Act of
2020 (15 U.S.C. 9401)) and other techniques to predict
whether the substances in a sample are controlled
substance analogues or other new psychoactive
substances not yet included in available reference
libraries.''.
SEC. 3. REQUIREMENTS.
In carrying out section 302(15) of the Homeland Security Act of
2002, as added by section 2, the Under Secretary for Science and
Technology shall--
(1) follow the recommendations, guidelines, and best
practices described in the Artificial Intelligence Risk
Management Framework (NIST AI 100-1) or any successor document
published by the National Institute of Standards and
Technology; and
(2) establish the Directorate of Science and Technology's
research, development, testing, evaluation, and cost-benefit
analysis priorities under such section 302(15) based on the
latest available information, including the latest State and
Territory Report on Enduring and Emerging Threats published by
the Drug Enforcement Administration or any successor document.
<all>